Kolon Life Science, Inc. operates in the bioscience industry in Korea and internationally. It engages in the manufacture and sale of pharmaceutical ingredients, and environmental and bio chemicals. The company’s active pharmaceutical ingredients include drugs for the circulatory system, anti-inflammatory drugs, drugs for the digestive and urinary system, antibiotics, and drugs for the periodentitis. Its environmental chemicals comprise functional chemicals consisting of paint, ink, catalysis, adhesive, and chemicals; technology-intensive products, such as agricultural chemicals; and biological activators, such as cosmetics and perfumes used for electronics and information, and environment and energy industries. The company’s environmental chemicals also include anti-bacterial agents for anti-fouling paints; antibacterial agent for building exterior and other industrial purpose; anti-bacterial agents for hair care; molecule coagulants; water treatment agents; antioxidants; flame retardants; and high refraction monomers. Its biological drugs comprise cell-mediated gene therapy and therapeutic protein drugs.